[Hormone therapies and ovarian cancer]

[Article in Finnish]

Affiliations

Review

[Article in Finnish]

Seija Grenman et al. Duodecim. 2002.

. 2002;118(4):349-56.

No abstract available

Similar articles

Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
American Medical Association. American Medical Association. Ginecol Obstet Mex. 2002 Aug;70:409-10. Ginecol Obstet Mex. 2002. PMID: 12448047 No abstract available.
Estrogen-progestogen replacement therapy and ovarian cancer: an update.
La Vecchia C. La Vecchia C. Eur J Cancer Prev. 2006 Dec;15(6):490-2. doi: 10.1097/01.cej.0000205026.14515.de. Eur J Cancer Prev. 2006. PMID: 17106327 Review.
Menopausal hormones and risk of ovarian cancer.
Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A. Moorman PG, et al. Am J Obstet Gynecol. 2005 Jul;193(1):76-82. doi: 10.1016/j.ajog.2004.11.013. Am J Obstet Gynecol. 2005. PMID: 16021062
Hormone replacement therapy and ovarian cancer risk--any news?
Riman T. Riman T. Acta Obstet Gynecol Scand. 2007;86(9):1032-4. doi: 10.1080/00016340701505341. Acta Obstet Gynecol Scand. 2007. PMID: 17712640 No abstract available.
[Risk of ovarian cancer in women treated for infertility].
Daya S. Daya S. Contracept Fertil Sex. 1994 Oct;22(10):593-6. Contracept Fertil Sex. 1994. Corrected and republished in: Contracept Fertil Sex. 1995 Jan;23(1):7-11. PMID: 7804376 Corrected and republished. Review. French. No abstract available.